STOCK TITAN

Accolade to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Accolade, Inc. (NASDAQ: ACCD) announced its participation in several upcoming investor conferences. Key events include the 41st Annual William Blair Growth Stock Conference on June 2, 2021, the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, and the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021. Each session will feature a fireside chat or presentation, providing insights into the company's innovative healthcare solutions aimed at improving health outcomes and reducing costs. For more details, visit ir.accolade.com.

Positive
  • None.
Negative
  • None.

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences:

  • The 41st Annual William Blair Growth Stock Conference, including a fireside chat on Wednesday, June 2, 2021 at 9:00 a.m. E.T.
  • The Goldman Sachs 42nd Annual Global Healthcare Conference, including a fireside chat on Tuesday, June 8, 2021 at 3:50 p.m. E.T.
  • The Stifel 2021 Virtual Cross Sector Insight Conference including a presentation on Thursday, June 10, 2021 at 2:00 p.m. E.T.

The webcast links and related presentation materials will be available at ir.accolade.com.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians and access to expert medical opinion services for high-cost treatment decisions. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at www.accolade.com.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200, Todd.Friedman@accolade.com

Asher Dewhurst, Investor Relations, 443-213-0500, accolade@westwicke.com

Media Contact:

Megan Torres, Public Relations, 206-926-8180, Megan.Torres@accolade.com

Source: Accolade


FAQ

When will Accolade participate in the William Blair Growth Stock Conference?

Accolade will participate in the William Blair Growth Stock Conference on June 2, 2021, at 9:00 a.m. E.T.

What is the date and time for Accolade's appearance at the Goldman Sachs Global Healthcare Conference?

Accolade will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 3:50 p.m. E.T.

When is Accolade scheduled to present at the Stifel Virtual Cross Sector Insight Conference?

Accolade is scheduled to present at the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021, at 2:00 p.m. E.T.

Where can I find the webcast links for Accolade's investor conference presentations?

The webcast links and presentation materials for Accolade's conferences will be available at ir.accolade.com.

What does Accolade, Inc. aim to achieve with its healthcare solutions?

Accolade aims to empower individuals to live healthier lives by simplifying healthcare navigation and improving health outcomes while lowering care costs.

Accolade, Inc.

NASDAQ:ACCD

ACCD Rankings

ACCD Latest News

ACCD Stock Data

270.60M
80.54M
3.07%
77.44%
6.38%
Health Information Services
Services-business Services, Nec
Link
United States of America
PLYMOUTH MEETING